← FDA Drug Approvals (Drugs@FDA)

NAPROXEN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2019-10-30

Drug application

FDA Application #

ANDA212199

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN SODIUM

Generic name

NAPROXEN SODIUM

Active ingredients

NAPROXEN SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals, Inc.

First approval

2019-10-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown